CHDRAUIB.MX
The company maintains a debt-to-equity ratio of 1.11, indicating a moderate level of leverage, while its current ratio of 0.92 suggests potential liquidity constraints. With a return on equity of 12.65% and a return on assets of 4.08%, the company's profitability is in line with typical performance metrics for the sector. The company's revenue is primarily concentrated in its core retail operations, with no significant geographic diversification reported in the available data. Looking ahead, the company is projected to maintain a stable growth trajectory, with no significant changes in revenue expected in the next fiscal year. The company faces moderate liquidity risk due to its negative net cash position after accounting for total debt, and while dilution risk is currently low, any future capital raising activities could affect shareholder value. Recent filings and transcripts have not indicated any major operational or strategic shifts, suggesting a stable business environment for the company.
Business. CHDRAUIB.MX operates in the Food & Drug Retailing industry, generating revenue primarily through the sale of food and drug products to consumers.
Classification. The company is classified under the Consumer Non-Cyclicals economic sector, specifically in the Food & Drug Retailing business sector, with a confidence level of 0.92.
- The company's debt-to-equity ratio of 1.11 indicates a moderate level of financial leverage.
- A return on equity of 12.65% suggests strong profitability relative to its equity base.
- The company's current ratio of 0.92 indicates potential liquidity constraints.
- The company's revenue is primarily concentrated in its core retail operations.
- The company is projected to maintain a stable growth trajectory with no significant changes in revenue expected.
- The company faces moderate liquidity risk due to its negative net cash position after accounting for total debt.
- # RATIONALES
- {
- Net cash is negative after subtracting total debt.